ANKRD30BL
gene geneOn this page
Summary
ANKRD30BL (ankyrin repeat domain 30B like, HGNC:35167) is a protein-coding gene on chromosome 2q21.2, encoding Putative ankyrin repeat domain-containing protein 30B-like (A7E2S9).
At a glance
- Clinical variants (ClinVar): 14 total
- MANE Select transcript:
NM_001358416
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:35167 |
| Approved symbol | ANKRD30BL |
| Name | ankyrin repeat domain 30B like |
| Location | 2q21.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000163046 |
| Ensembl biotype | protein_coding |
| Entrez | 554226 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 3 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay, 1 protein_coding, 1 retained_intron
ENST00000295181, ENST00000409867, ENST00000465868, ENST00000470729, ENST00000471048, ENST00000481691
RefSeq mRNA: 1 — MANE Select: NM_001358416
NM_001358416
CCDS: CCDS86883
Canonical transcript exons
ENST00000409867 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003514617 | 132150912 | 132150976 |
| ENSE00003517391 | 132154662 | 132154768 |
| ENSE00003518234 | 132156973 | 132157146 |
| ENSE00003624905 | 132147591 | 132148228 |
| ENSE00003680372 | 132157309 | 132157423 |
| ENSE00003914415 | 132161488 | 132161952 |
Expression profiles
Bgee: expression breadth ubiquitous, 105 present calls, max score 99.14.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0502 / max 5.1871, expressed in 31 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 30664 | 0.0501 | 31 |
| 30663 | 0.0001 | 0 |
Top tissues by expression
128 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| colonic epithelium | UBERON:0000397 | 99.14 | gold quality |
| bone marrow cell | CL:0002092 | 98.92 | gold quality |
| right testis | UBERON:0004534 | 85.60 | gold quality |
| left testis | UBERON:0004533 | 85.49 | gold quality |
| testis | UBERON:0000473 | 84.64 | gold quality |
| tonsil | UBERON:0002372 | 84.29 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 73.63 | gold quality |
| sural nerve | UBERON:0015488 | 72.66 | gold quality |
| bone marrow | UBERON:0002371 | 70.78 | gold quality |
| nucleus accumbens | UBERON:0001882 | 67.27 | gold quality |
| prefrontal cortex | UBERON:0000451 | 66.57 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 66.03 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 66.01 | gold quality |
| hypothalamus | UBERON:0001898 | 65.46 | gold quality |
| frontal cortex | UBERON:0001870 | 65.21 | gold quality |
| frontal lobe | UBERON:0016525 | 65.21 | gold quality |
| caudate nucleus | UBERON:0001873 | 64.87 | gold quality |
| amygdala | UBERON:0001876 | 64.81 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 64.77 | gold quality |
| cerebral cortex | UBERON:0000956 | 64.76 | gold quality |
| temporal lobe | UBERON:0001871 | 64.73 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 64.57 | gold quality |
| putamen | UBERON:0001874 | 63.93 | gold quality |
| Ammon’s horn | UBERON:0001954 | 63.82 | gold quality |
| right frontal lobe | UBERON:0002810 | 63.09 | gold quality |
| corpus callosum | UBERON:0002336 | 62.83 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 62.46 | silver quality |
| skeletal muscle tissue | UBERON:0001134 | 62.44 | gold quality |
| right uterine tube | UBERON:0001302 | 62.28 | gold quality |
| substantia nigra | UBERON:0002038 | 61.24 | gold quality |
Single-cell (SCXA)
Detected in 6 experiment(s), a significant marker in 4.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-HCAD-35 | yes | 59.99 |
| E-MTAB-9067 | yes | 55.56 |
| E-HCAD-25 | yes | 10.01 |
| E-ANND-3 | yes | 4.41 |
| E-MTAB-7381 | no | 718.96 |
| E-MTAB-6386 | no | 234.06 |
Regulation
Is transcription factor: no
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | si:ch211-272n13.3 | ENSDARG00000099768 |
| drosophila_melanogaster | CG8679 | FBGN0032934 |
| drosophila_melanogaster | CG42391 | FBGN0259737 |
| caenorhabditis_elegans | lem-3 | WBGENE00002276 |
| caenorhabditis_elegans | WBGENE00019483 | |
| caenorhabditis_elegans | WBGENE00206377 |
Paralogs (7): ANKRD26 (ENSG00000107890), ANKRD30A (ENSG00000148513), ANKRD18A (ENSG00000180071), ANKRD30B (ENSG00000180777), ANKRD62 (ENSG00000181626), ANKRD18B (ENSG00000230453), ANKRD20A1 (ENSG00000260691)
Protein
Protein identifiers
Putative ankyrin repeat domain-containing protein 30B-like — A7E2S9 (reviewed: A7E2S9)
All UniProt accessions (1): A7E2S9
UniProt curated annotations — full annotation on UniProt →
Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| A7E2S9-1 | 1 | yes |
| A7E2S9-2 | 2 |
RefSeq proteins (1): NP_001345345* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002110 | Ankyrin_rpt | Repeat |
| IPR036770 | Ankyrin_rpt-contain_sf | Homologous_superfamily |
| IPR050657 |
Pfam: PF00023, PF12796
UniProt features (10 total): repeat 4, region of interest 2, compositionally biased region 2, chain 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A7E2S9-F1 | 79.79 | 0.51 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 14 (showing top):
NFKBIA_TARGET_GENES, SRPK2_TARGET_GENES, GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_UP, GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_UP, GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_DN, BUSSLINGER_DUODENAL_TUFT_CELLS, HOEK_T_CELL_2011_2012_TIV_ADULT_7DY_UP, HOEK_NK_CELL_2011_2012_TIV_ADULT_7DY_UP, HOEK_T_CELL_2011_2012_TIV_ADULT_1DY_UP, HOEK_NK_CELL_2011_2012_TIV_3D_VS_0DY_ADULT_3D_DN, GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN, chr10q11, chr2q21, GSE45365_WT_VS_IFNAR_KO_CD11B_DC_DN
GO Biological Process (2): spliceosomal tri-snRNP complex assembly (GO:0000244), formation of quadruple SL/U4/U5/U6 snRNP (GO:0000353)
GO Molecular Function (2): protein binding (GO:0005515), U4 snRNA binding (GO:0030621)
GO Cellular Component (2): U6 snRNP (GO:0005688), U4/U6 x U5 tri-snRNP complex (GO:0046540)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| spliceosomal snRNP assembly | 1 |
| protein-RNA complex assembly | 1 |
| mRNA trans splicing, SL addition | 1 |
| binding | 1 |
| snRNA binding | 1 |
| spliceosomal snRNP complex | 1 |
| Lsm2-8 complex | 1 |
| U5 snRNP | 1 |
| U4/U6 snRNP | 1 |
| spliceosomal tri-snRNP complex | 1 |
Protein interactions and networks
STRING
844 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ANKRD30BL | STPG4 | Q8N801 | 528 |
| ANKRD30BL | SUGP1 | Q8IWZ8 | 488 |
| ANKRD30BL | TRIM48 | Q8IWZ4 | 393 |
| ANKRD30BL | SLC6A16 | Q9GZN6 | 370 |
| ANKRD30BL | ENTREP1 | Q15884 | 352 |
| ANKRD30BL | FRMD1 | Q8N878 | 349 |
| ANKRD30BL | SPAG8 | Q99932 | 348 |
| ANKRD30BL | PHACTR2 | O75167 | 314 |
| ANKRD30BL | PCMTD1 | Q96MG8 | 291 |
| ANKRD30BL | MBOAT1 | Q6ZNC8 | 290 |
| ANKRD30BL | ACOT13 | Q9NPJ3 | 264 |
| ANKRD30BL | COPS4 | Q9BT78 | 257 |
| ANKRD30BL | KIF21A | Q7Z4S6 | 256 |
| ANKRD30BL | AOPEP | Q8N6M6 | 253 |
| ANKRD30BL | DCAF6 | Q58WW2 | 252 |
| ANKRD30BL | PMF1 | Q6P1K2 | 252 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0PJZ0, A6NHY2, A7E2S9, C7B178, D3J162, G5E8K5, P42570, P42773, P53355, Q08E43, Q10311, Q14DN9, Q18297, Q2T9W8, Q3EC11, Q4R3S3, Q4R544, Q4UJC4, Q4UJJ2, Q5EFR1, Q5I126, Q5I148, Q5I155, Q5I159, Q5I160, Q5R6D7, Q5RCK5, Q5TYM7, Q5VYY1, Q60772, Q60773, Q6XJU9, Q80YE7, Q86WC6, Q91ZT9, Q91ZU0, Q92527, Q9BGT9, Q9CQM6, Q9D119
Diamond homologs: A0A0A6YYL3, A0JP26, A0PJZ0, A2A2Z9, A2RUR9, A5A3E0, A6NC57, A6NI47, A7E2S9, B2RU33, H3BUK9, P0CG38, P0CG39, Q3MJ40, Q4R3S3, Q4UJ75, Q5CZ79, Q5JPF3, Q5SQ80, Q5TYW2, Q5VUR7, Q6NSI1, Q6S545, Q6S5H5, Q6S8J3, Q6S8J7, Q811D2, Q86YR6, Q8IYA2, Q92527, Q9BXX2, Q9BXX3, Q9D504, Q9H560, Q9UPS8, Q8IVF6, A6QL64, Q8N2N9, Q8NF67, Q96IX9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
14 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 2 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
986 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:132153534:AG:A | donor_gain | 1.0000 |
| 2:132153555:A:AC | donor_gain | 1.0000 |
| 2:132153556:G:C | donor_gain | 1.0000 |
| 2:132153583:A:C | donor_gain | 1.0000 |
| 2:132153608:G:C | donor_gain | 1.0000 |
| 2:132154674:T:C | donor_gain | 1.0000 |
| 2:132156968:TCTAC:T | donor_loss | 1.0000 |
| 2:132156969:CTA:C | donor_loss | 1.0000 |
| 2:132156970:TAC:T | donor_loss | 1.0000 |
| 2:132156971:A:C | donor_loss | 1.0000 |
| 2:132156972:C:CG | donor_loss | 1.0000 |
| 2:132148226:CTT:C | acceptor_gain | 0.9900 |
| 2:132148229:C:CC | acceptor_gain | 0.9900 |
| 2:132150975:CG:C | acceptor_gain | 0.9900 |
| 2:132150977:C:CC | acceptor_gain | 0.9900 |
| 2:132150979:A:C | acceptor_gain | 0.9900 |
| 2:132150981:G:C | acceptor_gain | 0.9900 |
| 2:132150983:A:C | acceptor_gain | 0.9900 |
| 2:132153587:T:A | donor_gain | 0.9900 |
| 2:132153690:CTGTG:C | acceptor_gain | 0.9900 |
| 2:132153695:C:CC | acceptor_gain | 0.9900 |
| 2:132154657:TATA:T | donor_loss | 0.9900 |
| 2:132154658:ATACC:A | donor_loss | 0.9900 |
| 2:132154659:TACCA:T | donor_loss | 0.9900 |
| 2:132154660:A:C | donor_loss | 0.9900 |
| 2:132154672:TATCA:T | donor_gain | 0.9900 |
| 2:132154673:AT:A | donor_gain | 0.9900 |
| 2:132154673:ATCAA:A | donor_gain | 0.9900 |
| 2:132154722:T:A | donor_gain | 0.9900 |
| 2:132154727:A:AC | donor_gain | 0.9900 |
AlphaMissense
1708 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:132156976:G:C | N168K | 0.953 |
| 2:132156976:G:T | N168K | 0.953 |
| 2:132157075:A:C | D135E | 0.945 |
| 2:132157075:A:T | D135E | 0.945 |
| 2:132154707:A:G | L190S | 0.942 |
| 2:132157010:A:G | L157S | 0.939 |
| 2:132157047:C:G | A145P | 0.938 |
| 2:132161569:G:T | A46D | 0.926 |
| 2:132157077:C:G | D135H | 0.925 |
| 2:132157404:A:G | C80R | 0.924 |
| 2:132156977:T:A | N168I | 0.922 |
| 2:132154709:A:C | F189L | 0.919 |
| 2:132154709:A:T | F189L | 0.919 |
| 2:132154711:A:G | F189L | 0.919 |
| 2:132154744:C:G | A178P | 0.919 |
| 2:132157043:A:T | V146D | 0.916 |
| 2:132161499:A:C | D69E | 0.915 |
| 2:132161499:A:T | D69E | 0.915 |
| 2:132154743:G:T | A178D | 0.908 |
| 2:132157046:G:T | A145D | 0.908 |
| 2:132161643:G:C | F21L | 0.905 |
| 2:132161643:G:T | F21L | 0.905 |
| 2:132161645:A:G | F21L | 0.905 |
| 2:132161501:C:G | D69H | 0.903 |
| 2:132154667:A:C | F203L | 0.895 |
| 2:132154667:A:T | F203L | 0.895 |
| 2:132154669:A:G | F203L | 0.895 |
| 2:132156978:T:A | N168Y | 0.894 |
| 2:132157063:G:C | N139K | 0.891 |
| 2:132157063:G:T | N139K | 0.891 |
dbSNP variants (sampled 300 via entrez): RS1000031344 (2:132213457 T>A,C), RS1000102924 (2:132184230 G>A), RS1000167009 (2:132259567 C>T), RS1000223895 (2:132226559 C>A,T), RS1000252753 (2:132160431 A>G,T), RS1000286316 (2:132199466 C>A,T), RS1000295030 (2:132187002 A>G), RS1000295614 (2:132232090 G>A), RS1000327154 (2:132187318 G>A,C), RS1000357340 (2:132215930 A>T), RS1000387634 (2:132224443 T>C), RS1000388429 (2:132214845 A>C,G,T), RS1000394570 (2:132228657 A>C,G), RS1000405687 (2:132228868 A>G,T), RS1000447709 (2:132193340 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | affects expression, increases expression | 2 |
| Valproic Acid | affects expression, increases methylation | 2 |
| Aflatoxin B1 | decreases expression, decreases methylation, increases expression | 2 |
| ethyl-p-hydroxybenzoate | decreases expression | 1 |
| tris(2-butoxyethyl) phosphate | affects expression | 1 |
| jinfukang | increases expression | 1 |
| Benzo(a)pyrene | increases expression | 1 |
| 1-Methyl-4-phenylpyridinium | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.